Glucose metabolism drives embryonic development in mice, study reveals
Powered by WPeMatico
Powered by WPeMatico
Powered by WPeMatico
Gujarat- Recently, a cyber thug gang from Bareilly duped an MBBS student of Rs 2.80 lakh by promising him huge profits on completion of a task. On this, the medico has now filed a case against the cyber fraudsters in Baradari police station. Following the complaint, the police immediately started their investigation against the fraudsters.
The victim has been identified as a resident of Chhota Udaipur district of Gujarat. He is studying MBBS from a private medical college in Gujarat.
During the investigation, the victim medico told the police that the cyber thugs from Bareilly added him to a Telegram group and lured him with fake promises of completing certain tasks. The task was to add some products and to take a screenshot and send it to them. On the completion of this task, the victim was promised to get some money, however, the victim also received a small amount. This task continued for a few days and one day suddenly the fraudsters lured the victim to invest Rs 80 thousand and promised to return Rs 1.20 lakh, as per the Amar Ujala news report.
Falling prey to the trap of cyber fraudsters, the medico sent them 80 thousand rupees. In this way, money was transferred several times. To enhance the credibility of their scam, the fraudsters suddenly demanded Rs 3 lakh and on hearing this demand, he realised that he was being cheated. On this, the victim immediately filed a report of cyber fraud in Baradari police station. Currently, the case is under investigation.
In a similar incident that occurred recently in Hyderabad, two persons were arrested by the cyber crime police for allegedly cheating a 74-year-old doctor of Rs 1.6 crore in a fake money laundering case.
Powered by WPeMatico
Prayagraj: Slamming the State government for refusing to provide medical facilities to an undertrial prisoner, the Allahabad High Court emphasized that it is the state’s responsibility to provide care and medical facilities to undertrial prisoners during illness and cannot evade this duty.
Calling the government’s action ‘unjustified’, a single bench led by Justice Samit Gopal stated that the state cannot decline to provide treatment to an accused under custody with adequate medical facilities on any grounds.
The judge made these comments while criticizing the state authorities for refusing to provide medical or surgical help to an undertrial prisoner. The authorities had claimed that they couldn’t provide the treatment because the Model Code of Conduct for the 2024 Lok Sabha elections was in place at that time.
Following this, the court directed the District Magistrate of Deoria and the Superintendent of Police, Deoria, to personally look into the matter and file affidavits explaining why adequate arrangements were not made for the applicant’s surgery.
While hearing the matter, the judge said as quoted by Live Law, “This is entirely unacceptable. The accused is in custody under the state’s supervision. The state cannot refuse to provide him with adequate medical facilities on any grounds. In the present case, in the court’s opinion, the reason given by the Superintendent of the District Jail, Deoria, is completely unjustified.”
The court also instructed the officials to explain under what circumstances the applicant was denied surgery. It asked for an explanation of who was responsible for this, as the surgery, once recommended, should not have been delayed based on the discretion of the officials but should have been performed based on the doctors’ recommendations.
The case came to light after the prison authorities refused to act on a prior court order dated April 16, 2024, in which the Additional Sessions Judge of Deoria had directed that the prisoner be provided with adequate medical treatment as he was unwell in jail.
However, the jail superintendent refused to provide treatment, citing the Model Code of Conduct for the Lok Sabha elections. It was also stated that medical treatment would only be provided after the MCC was lifted.
Also read- Allahabad HC denies permission to 13-year-old rape survivor to terminate 32-week pregnancy
Powered by WPeMatico
New Delhi: While considering the plea by an MBBS aspirant with 88% muscular dystrophy, the Supreme Court recently observed that there were no specific guidelines available to assess disability with assistive devices in terms of the guidelines issued by the Government of India.
Therefore, to ascertain whether the candidate suffering from 88% muscular dystrophy is eligible for the MBBS admission, which was beyond the permissible limit of 80%, the top court bench of CJI DY Chandrachud and Justices JB Pardiwala and Manoj Misra have sought an expert opinion in this regard.
The bench referred to a recent Supreme Court judgment in the case of Omkar Ramchandra Gond vs Union of India and Others, where a three-judge bench had referred to Dr. Satendra Singh, the founder of an organisation named Infinite Ability.
Opining that a domain expert from the area would sub-serve the ends of justice of a young student seeking to pursue medical education, the top court bench comprising the CJI requested Dr. Singh to take up the assignment and assist the court on whether notwithstanding the quantified disability, the petitioner could pursue the MBBS degree course.
For this, the Court requested Dr. Singh to examine the petitioner and have due regard to such assistive devices and their potential to assist the petitioner to fulfill the requirements of the degree course in medicine.
“The report of Dr Satendra Singh may be submitted to this Court by 21 October 2024,” the Court order, listing the matter for further hearing on the same day.
Muscular Dystrophies are a genetically and clinically heterogeneous group of rare neuromuscular diseases causing progressive weakness and breakdown of skeletal muscles over time.
Since the petitioner’s disability was assessed to be more than the permissible limit of 80%, he was disqualified from pursuing MBBS course. However, challenging this decision he approached the Apex Court and based on the court’s order dated 3 October 2024, a five-Member Board of the All India Institute of Medical Sciences submitted a report evaluating the petitioner’s disability.
The said report stated, “The candidate was re-assessed with the assistive device (single hand crutch & motorised scooty). There was minimal to no change in most of the components for disability evaluation as per the GOI gazette (March 2024) with these assistive devices. The possibility of wheelchair usage was also explored which might be required for better efficiency in ambulation component in near future. However, there are no clear guidelines available to assess the disability with assistive devices as per the Govt. of India gazette guideline.”
“Further it is to be noted that safety, efficiency and agility of movements are needed to independently use the devices and many times some manual support is also required which may not be available to the candidate at all times and may affect the safety of the candidate and the patients during the skills based training provided in the various setups in the labs and hospitals during the MBBS course training. The Board after careful evaluations of all possibilities concurs with the opinion of the previous medical board held at AIIMS Nagpur dated 13.08.2024 that the disability is above 80% even with consideration of assistive devices and also both upper limbs have significant involvement and hence the candidate is ineligible to pursue MBBS course,” added the report.
After examining the report, the Apex Court noted that the AIIMS Committee noted that there were no clear guidelines available to assess disability with assistive devices in terms of the guidelines issued by the Government of India.
“We do not find that there is any independent evaluation on: (i) the extent of the functional disability of the petitioner; and (ii) the extent to which the use of assistive devices would have the potential to bring the extent of functional disability within permissible limits in terms of the government notification,” noted the Court.
Referring to the Court’s order in the case of Omkar Ramchandra Gond, the top court bench further observed,
“We are of the considered view that a domain expert from the area would sub-serve the ends of justice of a young student who seeks to pursue his career in medicine.”
Requesting Dr. Singh to assist the Court, the bench ordered, “…we request Dr Satendra Singh of Infinity Ability to take up the assignment which has been entrusted to him by the present order and to assist the Court on whether notwithstanding the quantified disability, the petitioner can pursue the MBBS degree course. In arriving at his evaluation, Dr Satendra Singh is requested to examine the petitioner and to have due regard to such assistive devices and their potential to assist the petitioner to fulfill the requirements of the degree course in medicine.”
Medical Dialogues had earlier reported that recently in the case of Omkar Ramchandra Gond, the Supreme Court held that mere existence of a benchmark disability of 40% or above will not disqualify a candidate from being eligible for MBBS admission unless a Disability Assessment Board opines that the candidate’s disability will come in the way of pursuing the course in question.
Further, the Apex Court bench of Justices BR Gavai, Aravind Kumar, and KV Viswanathan also observed that the Disability Assessment Boards should specify the reasons for holding that a candidate suffering from benchmark disability is not eligible to pursue the course.
The court further said that the National Medical Commission (NMC) regulations uniformly barring candidates with benchmark disabilities from medical education are overbroad and directed the NMC to revise its regulations adopting a more inclusive approach.
To view the order, click on the link below:
https://medicaldialogues.in/pdf_upload/supreme-court-disability-257466.pdf
Powered by WPeMatico
Itanagar: 14 out of the 25 districts in Arunachal Pradesh are now eligible for malaria-free certification, according to Dr KT Mulung, state program officer for the National Center for Vector Borne Disease Control (NCVBDC).
According to the PTI report, Mulung was speaking at the inauguration of the three-day state review meeting on vector-borne diseases organised by NCVBDC at Naharlagun near here.
The meeting focused on evaluating the state’s efforts towards malaria elimination and reviewing the progress in combating vector-borne diseases.
Additional Senior Regional Director of the Regional Offices of Health and Family Welfare, Shillong and Guwahati, Dr Juliana Lyngwa praised the remarkable reduction in malaria cases in the state.
Also Read:WHO Recommends new Malaria Vaccine for children which is cost-effective and efficient
Lyngwa attributed the achievement to the dedication of health officials and field staff.
She also stressed the importance of proper documentation to ensure smooth progress towards receiving malaria elimination certification.
State Family Welfare Director Dr Amping Perme underlined the department’s commitment to achieving a malaria-free Arunachal Pradesh in the near future, news agency PTI reported.
National Health Mission (NHM) Mission Director Marge Sora assured of proper allocation of funds for vector-borne disease control programmes.
The meeting, which will conclude on October 17, will review the strategies and develop actionable plans to accelerate the progress towards a malaria-free Arunachal Pradesh.
Medical Dialogues team had earlier reported that several hospitals in Delhi are seeing an increased footfall of dengue patients, doctors said, even as the city’s civic body has not released reports on vector-borne diseases for the last several weeks.
Sources at the Ram Manohar Lohia (RML) Hospital here said on Tuesday that a 38-year-old woman suffering from dengue died on September 17 at the Centre-run medical facility.
Powered by WPeMatico
Bengaluru: Gilead Sciences said on Friday it was voluntarily withdrawing its drug, Trodelvy, for previously treated patients with a type of bladder cancer after consultation with the U.S. health regulator.
The U.S. Food and Drug Administration had granted accelerated approval to Trodelvy, an antibody-drug conjugate, for metastatic urothelial cancer in 2021, while its continued approval was dependent on results of a confirmatory trial.
The drug, however, failed to improve survival for patients with advanced bladder cancer in the trial.
Shares of the drugmaker fell 1.3% to $86.25 in premarket trading
The decision does not affect approval for Trodelvy for other patients within or outside of the U.S., the company said.
Powered by WPeMatico
Powered by WPeMatico
Powered by WPeMatico
Separately, Kezar said its board has rejected Concentra Biosciences’ proposal to buy the company’s outstanding shares for $1.10 apiece in cash.
Powered by WPeMatico